Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2088-2100
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2088
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2088
Table 1 Final patient diagnoses
| Benign group (n = 22) | Malignant group (n = 12) | ||
| Chronic pancreatitis | 6 | Pancreatic cancer, stage (I/II/III/IV) | 9 (2/5/1/1/) |
| IPMN | 5 | Biliary ductal cancer, stage (I/II/III/IV) | 3 (1/2/0/0) |
| GB ADM | 3 | ||
| Autoimmune pancreatitis | 3 | ||
| CBD stricture of unknown origin | 2 | ||
| Serous cystic neoplasm | 2 | ||
| CBD stone | 1 | ||
- Citation: Sugimoto M, Abe K, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, Irie H, Watanabe K, Nakamura J, Kikuchi H, Takasumi M, Hashimoto M, Kato T, Kobashi R, Hikichi T, Ohira H. Dysbiosis of the duodenal microbiota as a diagnostic marker for pancreaticobiliary cancer. World J Gastrointest Oncol 2021; 13(12): 2088-2100
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2088.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2088